Atazanavir Sulfate
- Product NDC
- 51407-171
- 11-digit product format
- 514070171
- Labeler code
- 51407
- Product ID
- 51407-171_b0a4420a-7458-41b1-e053-2995a90a5f9b
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Atazanavir Sulfate
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Golden State Medical Supply Inc.
- Application
- ANDA091673
- Marketing category
- ANDA
- Marketing start
- 2017-12-27
- Marketing end
- 2020-11-30
- Substance
- ATAZANAVIR SULFATE
- Active strength
- 150 mg/1
- Pharmacologic classes
- HIV Protease Inhibitors [MoA],Protease Inhibitor [EPC],UGT1A1 Inhibitors [MoA],UDP Glucuronosyltransferases Inhibitors [MoA],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 3A Inhibitors [MoA],Cytochrome P450 2C8 Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record